|175.26||+0.7200||+0.41%||Vol 269.38K||1Y Perf -10.71%|
|May 13th, 2022 16:00 DELAYED|
|- -%||- -|
|Target Price||250.00||Analyst Rating||Strong Buy 1.50|
|Potential %||42.65||Finscreener Ranking||★★+ 46.75|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★ 50.50|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★ 58.68|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||6.80||Earnings Rating||Sell|
|Market Cap||4.19B||Earnings Date||9th May 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||1.53|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||517.96K|
|Avg. Monthly Volume||232.29K|
|Avg. Quarterly Volume||233.37K|
ICU Medical Inc. (NASDAQ: ICUI) stock closed at 175.26 per share at the end of the most recent trading day (a 0.41% change compared to the prior day closing price) with a volume of 269.38K shares and market capitalization of 4.19B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 8000 people. ICU Medical Inc. CEO is Vivek Jain.
The one-year performance of ICU Medical Inc. stock is -10.71%, while year-to-date (YTD) performance is -26.16%. ICUI stock has a five-year performance of 6.83%. Its 52-week range is between 167.47 and 282, which gives ICUI stock a 52-week price range ratio of 6.80%
ICU Medical Inc. currently has a PE ratio of 43.50, a price-to-book (PB) ratio of 3.05, a price-to-sale (PS) ratio of 4.81, a price to cashflow ratio of 16.80, a PEG ratio of 2.32, a ROA of 5.86%, a ROC of 6.46% and a ROE of 6.84%. The company’s profit margin is 7.95%, its EBITDA margin is 16.20%, and its revenue ttm is $998.26 Million , which makes it $41.80 revenue per share.
Of the last four earnings reports from ICU Medical Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.53 for the next earnings report. ICU Medical Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for ICU Medical Inc. is Strong Buy (1.5), with a target price of $250, which is +42.65% compared to the current price. The earnings rating for ICU Medical Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
ICU Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
ICU Medical Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.67, ATR14 : 9.20, CCI20 : -160.41, Chaikin Money Flow : 0.00, MACD : -11.63, Money Flow Index : 25.60, ROC : -17.45, RSI : 25.22, STOCH (14,3) : 14.86, STOCH RSI : 0.11, UO : 39.45, Williams %R : -85.14), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of ICU Medical Inc. in the last 12-months were: Brian Bonnell (Sold 0 shares of value $0 ), Christian Voigtlander (Sold 0 shares of value $0 ), Daniel Woolson (Option Excercise at a value of $0), David C. Greenberg (Sold 0 shares of value $0 ), David F. Hoffmeister (Sold 0 shares of value $0 ), Donald M. Abbey (Sold 0 shares of value $0 ), Elisha W. Finney (Sold 0 shares of value $0 ), Elisha W. Finney (Sold 2 641 shares of value $624 101 ), George A. Lopez (Option Excercise at a value of $711 676), Kevin J. McGrody (Sold 0 shares of value $0 ), Kolleen T. Kennedy (Sold 0 shares of value $0 ), Laurie Hernandez (Sold 0 shares of value $0 ), Robert S. Swinney (Option Excercise at a value of $65 430), Robert S. Swinney (Sold 6 657 shares of value $1 437 945 ), Virginia Ruth Sanzone (Option Excercise at a value of $0), Virginia Ruth Sanzone (Sold 1 550 shares of value $331 411 ), Vivek Jain (Option Excercise at a value of $1 410 960), Vivek Jain (Sold 24 000 shares of value $5 760 057 )
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.